dc.creatorParodi, Cecilia
dc.creatorBadano, Maria Noel
dc.creatorGalassi, Nora Virginia
dc.creatorCoraglia, Ana Carina
dc.creatorBaré, Patricia
dc.creatorMalbrán, Alejandro
dc.creatorde Elizalde, Maria Marta
dc.date.accessioned2019-09-27T01:05:12Z
dc.date.accessioned2022-10-15T08:39:03Z
dc.date.available2019-09-27T01:05:12Z
dc.date.available2022-10-15T08:39:03Z
dc.date.created2019-09-27T01:05:12Z
dc.date.issued2014-11
dc.identifierParodi, Cecilia ; Badano, Maria Noel; Galassi, Nora Virginia; Coraglia, Ana Carina; Baré, Patricia; et al.; Follicular helper T lymphocytes (TFH) in health and disease; BaiShideng Publishing Group; World Journal of Hematology; 4; 3; 11-2014; 118-127
dc.identifier2218-6204
dc.identifierhttp://hdl.handle.net/11336/84640
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4365991
dc.description.abstractA correct antibody response requires the participationof both B and T lymphocytes and antigen presentingcells. In this review we address the role of follicularhelper T lymphocytes (TFH) in this reaction. We shall focuson the regulation of their development and functionin health and disease. TFH can be characterized on thebasis of their phenotype and the pattern of secretionof cytokines. This fact is useful to study their participationin the generation of antibody deficiency in primaryimmunodeficiency diseases such as common variableimmunodeficiency, X-linked hyper IgM syndrome orX-linked lymphoproliferative disease. Increased numbersof TFH have been demonstrated in several autoimmunediseases and are thought to play a role in thedevelopment of autoantibodies. In chronic viral infectionscaused by the human immunodeficiency virus,hepatitis B or C virus, increased circulating TFH havebeen observed, but their role in the protective immuneresponse to these agents is under discussion. Likewise,an important role of TFH in the control of some experimentalprotozoan infections has been proposed, and itwill be important to assess their relevance in order todesign effective vaccination strategies.
dc.languageeng
dc.publisherBaiShideng Publishing Group
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.wjgnet.com/2218-6204/full/v3/i4/118.htm
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.5315/wjh.v3.i4.118
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFOLLICULAR HELPER LYMPHOCYTES
dc.subjectTFH DEVELOPMENT
dc.subjectCHEMOKINE RECEPTOR 5
dc.subjectINTERLEUKIN-21
dc.subjectPROGRAMMED CELL DEATH-1 /PROGRAMMED CELL DEATH LIGAND 1 (PDL-1) OR PDL-2
dc.subjectPRIMARY IMMUNODEFICIENCES
dc.subjectAUTOIMMUNITY
dc.subjectCHRONIC VIRAL INFECTIONS
dc.subjectPROTOZOAN INFECTIONS
dc.titleFollicular helper T lymphocytes (TFH) in health and disease
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución